Ampliphi Biosciences Corp (NYSEAMERICAN:APHB) gapped down prior to trading on Thursday . The stock had previously closed at $1.95, but opened at $1.50. Ampliphi Biosciences shares last traded at $1.12, with a volume of 4194000 shares traded.

Separately, HC Wainwright set a $5.00 price objective on shares of Ampliphi Biosciences and gave the stock a “buy” rating in a research report on Monday, October 2nd.

The firm has a market cap of $10.64, a PE ratio of -0.11 and a beta of 2.93.

TRADEMARK VIOLATION WARNING: “Ampliphi Biosciences (APHB) Shares Gap Down to $1.50” was first reported by Watch List News and is owned by of Watch List News. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and international copyright law. The correct version of this report can be viewed at

Ampliphi Biosciences Company Profile

AmpliPhi Biosciences Corporation is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.

Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with's FREE daily email newsletter.